Variant transthyretin amyloidosis (ATTRv) is a rare, progressive, clinically heterogenous and life-threatening disease caused by extracellular deposition of amyloid fibrils formed of mutant transthyretin (TTR) [1–3]. Here, TTR is linked to prealbumin measurement.